B. Brenner

2.3k total citations · 1 hit paper
21 papers, 1.7k citations indexed

About

B. Brenner is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B. Brenner has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B. Brenner's work include Blood disorders and treatments (7 papers), Platelet Disorders and Treatments (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). B. Brenner is often cited by papers focused on Blood disorders and treatments (7 papers), Platelet Disorders and Treatments (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). B. Brenner collaborates with scholars based in Israel, Austria and Switzerland. B. Brenner's co-authors include Paul A. Kyrle, Max Solenthaler, U. Mittler, Bernhard Lämmle, I. Scharrer, Rodolfo Robles, Miha Furlan, V. Aumann, Manuela Krause and Miriam Galbusera and has published in prestigious journals such as New England Journal of Medicine, Blood and Kidney International.

In The Last Decade

B. Brenner

20 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

1998 1.3k citations Miha Furlan, Rodolfo Robles et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by B. Brenner

Since Specialization

Citations

This map shows the geographic impact of B. Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Brenner more than expected).

Fields of papers citing papers by B. Brenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Brenner. The network helps show where B. Brenner may publish in the future.

Co-authorship network of co-authors of B. Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of B. Brenner. A scholar is included among the top collaborators of B. Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Brenner. B. Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Myeloma and thrombotic complications. 2013 ·PubMed ·Inna Tzoran, B. Brenner, R Hoffman	1
2	PO-04 Heparanase induces TFPI expression and extracellular accumulation in endothelial and tumor cells 2007 ·Thrombosis Research ·Yona Nadir, B. Brenner, Svetlana Gingis‐Velitski, Flonia Levy‐Adam, Neta Ilan, Eyal Zcharia, (unknown), Israël Vlodavsky	2
3	Prospective Evaluation of Hemostatic System Activation and Thrombin Potential in Healthy Pregnant Women with and without Factor V Leiden 1999 ·Thrombosis and Haemostasis ·Ansgar Weltermann, K Philipp, E. Hafner, (unknown), (unknown), B. Brenner, Christine Mannhalter, Klaus Lechner, (unknown), Sabine Eichinger	83
4	von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome breakdown → 1998 ·New England Journal of Medicine ·Miha Furlan, Rodolfo Robles, Miriam Galbusera, Giuseppe Remuzzi, Paul A. Kyrle, B. Brenner, Manuela Krause, I. Scharrer, V. Aumann, U. Mittler, Max Solenthaler, Bernhard Lämmle	1254
5	Platelet activation in patients with antiphospholipid syndrome 1998 ·Blood Coagulation & Fibrinolysis ·Yoram Shechter, Yuval Tal, Harry B. Greenberg, B. Brenner	5
6	Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene 1998 ·Arteriosclerosis Thrombosis and Vascular Biology ·Paul A. Kyrle, Christine Mannhalter, Suzette Beguı́n, A Stümpflen, Mirko Hirschl, Ansgar Weltermann, Milena Stain, B. Brenner, Wolfgang Speiser, Ingrid Pabinger, Klaus Lechner, Sabine Eichinger	125
7	Multiple Myeloma with Pericardial Involvement and Cardiac Tamponade: A Report of Three Patients 1996 ·Leukemia & lymphoma ·(unknown), R Hoffman, (unknown), B. Brenner, Arie Markel, (unknown), Jacob M. Rowe	13
8	Clinical experience with Octagam, a solvent detergent (SD) virus inactivated intravenous gammaglobulin. 1996 ·PubMed ·B. Brenner	10
9	[Symptomatic antiphospholipid antibody after neuroleptic drugs]. 1995 ·PubMed ·B. Brenner, Lore Metz	2
10	Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX 1994 ·Blood ·(unknown), (unknown), B. Brenner, KJ Clemetson	60
11	Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX 1994 ·Blood ·(unknown), (unknown), B. Brenner, KJ Clemetson	4
12	Carbamazepine (Tegretol)‐Induced Thrombocytopenia 1993 ·Vox Sanguinis ·(unknown), B. Brenner, Ehud Klein, I. Tatarsky	2
13	Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo 1992 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Brunhilde Wagner, Hans‐Georg Eichler, Barbara Schneider, (unknown), B. Brenner, S. Gasić, Klaus Lechner, (unknown)	2
14	Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. 1992 ·PubMed ·B. Brenner, (unknown), (unknown), I. Tatarsky, Margalit Lorber	5
15	Angioedema during therapy with recombinant tissue plasminogen activator. 1991 ·PubMed ·C. W. Francis, B. Brenner, (unknown), VJ Marder	26
16	Rapid neonatal diagnosis of type IIB von Willebrand disease using the polymerase chain reaction [letter] 1991 ·Blood ·Christine Mannhalter, (unknown), B. Brenner, Klaus Lechner	6
17	Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF 1990 ·Kidney International ·(unknown), Felix Stockenhuber, Barbara Schneider, Ingrid Pabinger, B. Brenner, Brunhilde Wagner, P Balcke, Klaus Lechner, Paul A. Kyrle	23
18	Effect of ritanserin, a 5-hydroxytryptamine2– receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivo 1990 ·Clinical Pharmacology & Therapeutics ·Brunhilde Wagner, Barbara Schneider, (unknown), Wolfgang Speiser, B. Brenner, (unknown), Klaus Lechner, Paul A. Kyrle	6
19	Thromboxane A2 and Prostacyclin Generation in the Microvasculature of Patients with Atherosclerosis – Effect of Low-Dose Aspirin 1989 ·Thrombosis and Haemostasis ·Paul A. Kyrle, E Minar, B. Brenner, H G Eichler, (unknown), L Marosi, Klaus Lechner	14
20	Evidence for an Increased Generation of Prostacyclin in the Microvasculature and an Impairment of the Platelet α-Granule Release in Chronic Renal Failure 1988 ·Thrombosis and Haemostasis ·Paul A. Kyrle, Felix Stockenhuber, B. Brenner, Heinz Gössinger, C Korninger, Ingrid Pabinger, Gere Sunder‐Plassmann, P Balcke, Klaus Lechner	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact